View More
Learn about the metabolic adaptations in obesity, the value of sustained weight loss, and the latest evidence for incretin-based therapies for long-term weight management.
Here’s how I dose incretins and how I address potential GI adverse events, pancreatitis, and gallstones.
From ENDO 2021, expert faculty assess the metabolic adaptations in obesity, the value of sustained weight loss, and the latest evidence for incretin-based therapies for long-term weight management
For questions about content or obtaining CME credit, please contact the Endocrine Society at www.education.endocrine.org/contact.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.